MYSULIN 30/70 (100 IU) PENSET 3ML

MYSULIN 30/70 (100 IU) PENSET 3ML

Availability :

Out Of Stock

Product Code : 106514902100401

Short Description

MYSULIN 30/70 PENSET is a pre-filled insulin pen used to control blood sugar levels in diabetes patients, providing both rapid and long-lasting effects in a convenient, easy-to-use format.

Name	Brand	Generic Name	Strength	PPF	Price
MYSULIN 30/70 (100 IU) PENSET 3ML	Drug International Ltd.	HUMAN INSULIN	3ml	INSULIN	222

৳ 222

Select Color

Select Size

Qty :

Description

• রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন।

Indications:

MYSULIN 30/70 PENSET is indicated for the treatment of diabetes mellitus, including:

Type 1 diabetes (insulin-dependent diabetes).
Type 2 diabetes (non-insulin dependent diabetes) when blood sugar levels are not adequately controlled by diet, exercise, or oral hypoglycemic agents.

It is especially useful for patients who need a combination of both short-acting and long-acting insulin to maintain their blood sugar levels.

Pharmacology:

MYSULIN 30/70 PENSET contains a mixture of two types of insulin:

Regular insulin (30%): A short-acting insulin that works quickly to lower blood glucose levels, typically within 30 minutes of injection, with a duration of 6–8 hours.
Isophane insulin (NPH, 70%): A long-acting insulin that works gradually to lower blood glucose levels over a longer period, typically lasting 12–16 hours.

This combination of short-acting and long-acting insulins helps provide a more stable and controlled reduction in blood glucose levels, both after meals and throughout the day.

Dosage:

The dosage of MYSULIN 30/70 PENSET is highly individualized, depending on the patient's blood sugar levels, body weight, and response to insulin therapy.
Initial dose for adults may range from 0.5 to 1 unit per kg of body weight, typically administered 1–2 times daily.
Adjustments: Dose may be adjusted based on blood glucose levels and physician's advice.
Always follow your healthcare provider’s dosage instructions.

Administration:

MYSULIN 30/70 PENSET is for subcutaneous injection only.
It is typically injected into the fatty tissue of the abdomen, thigh, or upper arm.
Rotate injection sites regularly to avoid irritation or lipodystrophy.
Prime the pen before the first injection if using the pen for the first time.
Make sure to check the insulin before use to ensure it is well mixed (the pen should be gently rolled before use).
Injection frequency: Generally, one or two injections per day, depending on the specific needs of the patient and as directed by the healthcare provider.

Interaction:

MYSULIN 30/70 PENSET may interact with:

Other diabetic medications (oral hypoglycemics like sulfonylureas or metformin).
Corticosteroids, diuretics, and beta-blockers can affect insulin requirements or blood sugar control.
Alcohol may increase the risk of hypoglycemia (low blood sugar).
Always inform your doctor of any other medications you are taking before starting insulin therapy.

Contraindications:

Hypersensitivity to insulin or any component of the pen formulation.
Active infections, including fungal infections.
Ketoacidosis (diabetic coma).
Severe hypoglycemia.
Undiagnosed or untreated adrenal insufficiency or thyroid disorders.

Side Effects:

Common side effects: Hypoglycemia (low blood sugar), injection site reactions (redness, swelling, itching), weight gain, and fluid retention.
Serious side effects: Hypoglycemic coma, allergic reactions (e.g., anaphylaxis), lipodystrophy (skin changes at the injection site), and swelling of the face or throat.
Other effects: Changes in vision, dizziness, and fatigue may occur with improper dosing or blood sugar fluctuations.

Pregnancy & Lactation:

MYSULIN 30/70 PENSET is generally safe to use during pregnancy when blood sugar levels must be controlled. It is crucial for the health of both the mother and baby to maintain stable glucose levels during pregnancy.
The drug passes into breast milk in small amounts but is generally considered safe for breastfeeding mothers. Consult with your healthcare provider for the best approach.

Therapeutic Class:

Insulin (Combination Short-acting & Long-acting)

Storage Conditions:

Store the insulin pen in a refrigerator (2°C to 8°C) before first use.
After the first use, the pen may be stored at room temperature (up to 25°C) for up to 4 weeks.
Do not freeze the insulin pen.
Keep the pen away from heat and direct sunlight, and store it out of reach of children.